Published: 31. May, 2021
Clinical trial 0204 in 12 healthy volunteers investigating the absolute bioavailability of CT001, reports…
Clinical trial 0204 in 12 healthy volunteers investigating the absolute bioavailability of CT001, reports last subject dosed ahead of timelines. Primary aim of the trial is to demonstrate drug-exposure following nasal administration of CT001 relative to the IV injection of the approved analgesic drugs
28. February, 2025
Today, Friday 28. February, Cessatech has released the Annual Report for 20024. We have...
4. February, 2025
On 4 February – Cessatech A/S (“Cessatech” or “the Company”) announces that the Company...
16. October, 2024
Cessatech announces that recruitment has today reached the halfway point for patient recruitment with...
Subscribe and get notified on Cessatech's latest news.
An acceptance email will be sent to you, please check your spam.